Back to results
US 2026/0232636 A1Published application
Inhibitors of lrrk2
AssigneeVanderbilt University
InventorsCraig W. Lindsley, Changho Han, Upendra Rathnayake, Joseph D. Bungard, Hyekyung Kelly Plumley
Life of this patent
Estimating the term…
Abstract
Indazole- and azaindazole-substituted octahydrocyclopenta[c]pyrrole and hexahydrocyclopenta[c]pyrrole compounds are inhibitors of LRRK2. The compounds and their pharmaceutical compositions may be used in the treatment of CNS disorders such as familial/genetic and/or sporadic Parkinson's disease, a tauopathy, or Alzheimer's disease.
Claims34
A compound of formula (I):
- or a pharmaceutically acceptable salt thereof, wherein:
- “” represents a single bond or a double bond;
- R1 is
- R1a is G1, -L1-G1, —C2-4alkylene-ORA, —C2-4alkylene-NRARB, C1-6alkyl, C1-6fluoroalkyl, or H;
- RA is G1, -L1-G1, C1-6alkyl, C1-6fluoroalkyl, C3-6cycloalkyl, or —C1-3alkylene-C3-6cycloalkyl;
- RB is H, C1-6alkyl, C1-6fluoroalkyl, C3-6cycloalkyl, or —C1-3alkylene-C3-6cycloalkyl;
- R1b is halogen, C1-4alkyl, C1-2fluoroalkyl, CN, C3-4cycloalkyl, —OC1-3alkyl, —OC1-2fluoroalkyl, or H;
- R1c is H, halogen, C1-4alkyl, C1-2fluoroalkyl, CN, phenyl, C3-4cycloalkyl, —OR1d, or —N(R1d)2;
- R1d, at each occurrence, is independently H, C1-4alkyl, C1-2fluoroalkyl, C3-4cycloalkyl, or —C1-3alkylene-C3-4cycloalkyl, wherein alternatively two R1d, together with a nitrogen to which the two R1d attach form a 4- to 6-membered heterocyclic ring optionally substituted with 1-4 substituents independently selected from the group consisting of halogen and C1-4alkyl;
- L1 is C1-5alkylene or C2-5alkenylene;
- G1 is a 5- to 6-membered aromatic or partially unsaturated heterocyclic ring containing a first nitrogen and optionally 1-2 additional heteroatoms that are independently nitrogen, oxygen, or sulfur, the heterocyclic ring being attached at an unsaturated carbon in the heterocyclic ring or G1 is phenyl, G1 being optionally substituted with a first substituent selected from the group consisting of halogen, C1-4alkyl, cyano, C1-2fluoroalkyl, oxo, —OR10, —N(R10)2, —C1-3alkylene-OR10, C3-5cycloalkyl, and —C1-3alkylene-C3-5cycloalkyl, and optionally further substituted with 1-2 substituents independently selected from the group consisting of halogen, C1-4alkyl, cyano, and C1-2fluoroalkyl;
- R10, at each occurrence, is independently H, C1-4alkyl, C1-2fluoroalkyl, C3-4cycloalkyl, or —C1-3alkylene-C3-4cycloalkyl, wherein alternatively two R10, together with a nitrogen to which the two R10 attach form a 4- to 6-membered heterocyclic ring optionally substituted with 1-4 substituents independently selected from the group consisting of halogen and C1-4alkyl;
- R2 is G2, -L2-G2, -L3-C1-6alkyl, —C2-6alkylene-R2a, C1-6alkyl, C1-6fluoroalkyl, or H;
- L2 is C1-3alkylene or L3;
- L3 is C(O), SO2, S(O)(NH), C(O)NH, or C(O)O;
- G2 is a 4- to 12-membered heterocyclyl, a C3-12carbocyclyl, a 5- to 12-membered heteroaryl, or a 6- to 12-membered aryl, wherein G2 is optionally substituted with a first substituent selected from the group consisting of halogen, cyano, C1-4alkyl, C1-2fluoroalkyl, G2a, oxo, —OR13, —N(R13)2, —C1-3alkylene-OR13, —C1-3alkylene-N(R13)2, —C(O)N(R13)2, —C(O)OR13, —SO2R13 and S(O)(NH)R13, optionally further substituted with oxo, and optionally further substituted with 1-3 substituents independently selected from the group consisting of halogen, cyano, C1-4alkyl, and C1-2fluoroalkyl;
- G2a is a C3-4cycloalkyl;
- R13, at each occurrence, is independently H, C1-4alkyl, C1-2fluoroalkyl, C3-4cycloalkyl, or —C1-3alkylene-C3-4cycloalkyl, wherein alternatively two R13, together with a nitrogen to which the two R13 attach form a 4- to 6-membered heterocyclic ring optionally substituted with 1-4 substituents independently selected from the group consisting of halogen and C1-4alkyl;
- R2a is —OR14, —N(R14)2, —SO2R14, S(O)(NH)R14, —NR14C(O)N(R14)2, or —NR14C(O)OR14;
- R14, at each occurrence, is independently H, C1-4alkyl, C1-2fluoroalkyl, C3-4cycloalkyl, or —C1-3alkylene-C3-4cycloalkyl, wherein alternatively two R14, together with a nitrogen to which the two R14 attach form a 4- to 6-membered heterocyclic ring optionally substituted with 1-4 substituents independently selected from the group consisting of halogen and C1-4alkyl;
- R3, at each occurrence, is independently fluoro or C1-4alkyl;
- and
- n is 0, 1, or 2.
20 more elements
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
30-31. (canceled)
35-38. (canceled)
Dependencies are inferred from the claim text.